Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS
Retrieved on:
Monday, October 2, 2023
General Health, Consumer, Health, Parenting, Baby, Maternity, SIDS, Education, Life, Parent, Tree, Sleep, Hope, Leg, Research, Attention, Biomarker, Pain, Sydney Children's Hospital, Risk, Child, Knowledge, Entrepreneurship, Infant, Caregiver, SUID, Family, NYSE, GoFundMe, OWLT, Birth control, Toy, Pharmaceutical industry, Owlet
Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS).
Key Points:
- Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS).
- Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone 1.
- Along with providing direct funding, Owlet supports parents of loss through various Owlet Cares initiatives.
- “This and every month, we invite parents and caregivers to join us and participate in a historical movement to end SIDS.